Therapy

Athersys to Host Third Quarter Financial Results Call

Monday, October 14, 2019 - 6:00pm

We encourage shareholders to listen using the webcast link and to use the phone line if you intend to ask a question.

Key Points: 
  • We encourage shareholders to listen using the webcast link and to use the phone line if you intend to ask a question.
  • A replay will be available on the webcast at www.athersys.com under the investors section approximately two hours after the call has ended.
  • Athersys is an international biotechnology company engaged in the development of therapeutic products designed to extend and enhance the quality of human life.
  • Athersys has forged strategic partnerships and a broad network of collaborations to further advance MultiStem cell therapy toward commercialization.
Tags: 
Health, Articles, Drug discovery, Health policy, Medicinal chemistry, Therapy

Joint Partnership Between MedRisk and Raintree Systems to Reduce Administrative Burden and Expedite Payment for Physical Therapy

Friday, October 11, 2019 - 7:17pm

MedRisk and Raintree Systems have announced a joint partnership to reduce the administration burden for physical therapists in workers compensation.

Key Points: 
  • MedRisk and Raintree Systems have announced a joint partnership to reduce the administration burden for physical therapists in workers compensation.
  • MedRisk, the leader in physical rehabilitation in workers compensation, will integrate with Raintrees practice management and electronic medical record software, which was designed specifically for physical therapy.
  • The partnership with Raintree delivers value to patients, providers, and claims professionals, said MedRisks Chief Strategy Officer Michelle Buckman.
  • Raintree Systems is an industry leader that provides the most complete and comprehensive practice solutions for Rehabilitation & Therapy.
Tags: 
Practice Management, Physical therapy, Managed care, Professional services, Health, Insurance, Human resources, Finance, Health, Medical specialties, Rehabilitation medicine, Manual therapy, Physical exercise, Physical therapy, Therapy

Axovant Gene Therapies Announces Upcoming Presentations at the European Society of Gene and Cell Therapy 27th Annual Congress

Thursday, October 10, 2019 - 1:00pm

NEW YORK and BASEL, Switzerland, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies, Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced upcoming presentations regarding its investigational gene therapy programs, AXO-Lenti-PD, AXO-AAV-GM1 and AXO-AAV-GM2, at the European Society of Gene and Cell Therapy (ESGCT) 27th Annual Congress, held in Barcelona, Spain, October 22-25, 2019.

Key Points: 
  • NEW YORK and BASEL, Switzerland, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies, Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced upcoming presentations regarding its investigational gene therapy programs, AXO-Lenti-PD, AXO-AAV-GM1 and AXO-AAV-GM2, at the European Society of Gene and Cell Therapy (ESGCT) 27th Annual Congress, held in Barcelona, Spain, October 22-25, 2019.
  • Our current pipeline of gene therapy candidates targets GM1 gangliosidosis, GM2 gangliosidosis (including Tay-Sachs disease and Sandhoff disease), and Parkinsons disease.
  • Axovant is focused on accelerating product candidates into and through clinical trials with a team of experts in gene therapy development and through external partnerships with leading gene therapy organizations.
  • All forward-looking statements are based on estimates and assumptions by Axovants management that, although Axovant believes to be reasonable, are inherently uncertain.
Tags: 
Branches of biology, Lipid storage disorders, Rare diseases, Health, Articles, GM2 gangliosidoses, Sandhoff disease, Gangliosidosis, Tay–Sachs disease, Gene therapy, GM1, Therapy

ASGCT Kicks Off Second Round of Gene Therapy Education Resources

Thursday, October 10, 2019 - 12:00pm

MILWAUKEE, Oct. 10, 2019 /PRNewswire-PRWeb/ --The American Society of Gene & Cell Therapy (ASGCT) is proud to announce the launch of a second group of disease-specific resources from its Patient Education program , a new initiative in 2019.

Key Points: 
  • MILWAUKEE, Oct. 10, 2019 /PRNewswire-PRWeb/ --The American Society of Gene & Cell Therapy (ASGCT) is proud to announce the launch of a second group of disease-specific resources from its Patient Education program , a new initiative in 2019.
  • The first of the seven new resources focuses on developing gene therapies for Parkinson's disease.
  • Beginning today, October 10, ASGCT will release brand new resources weekly through the end of November on the new Patient Education portal .
  • The full schedule for ASGCT's new Patient Education resources to be released during the remainder of 2019, excepting a one-week break for the ASGCT Policy Summit is as follows:
Tags: 
Health, Articles, Drug discovery, Health policy, Medicinal chemistry, Therapy, Parkinson's disease

CytoSorbents to Present at The MicroCap Rodeo Investor Conference

Thursday, October 10, 2019 - 12:00pm

An archived replay of the webcast will be available for one year following the event.

Key Points: 
  • An archived replay of the webcast will be available for one year following the event.
  • CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification.
  • These are conditions where the risk of death is extremely high, yet no effective treatments exist.
  • For more information, please visit the Company's websites at www.cytosorbents.com and www.cytosorb.com or follow us on Facebook and Twitter .
Tags: 
Operating systems, Software, World Wide Web, Social media, Universal Windows Platform apps, Social networking services, Immunotherapy, Virotherapy, Twitter, Therapy, Facebook

ImaginAb To Present At Innovation Showcase 2019 Hosted By The Lundquist Institute

Wednesday, October 9, 2019 - 2:20pm

ImaginAb Inc. is an immuno-oncology imaging company focused on providing actionable insight into patient selection and treatment progress for cancer immunotherapy, enabling precision medicine.

Key Points: 
  • ImaginAb Inc. is an immuno-oncology imaging company focused on providing actionable insight into patient selection and treatment progress for cancer immunotherapy, enabling precision medicine.
  • ImaginAb engineers antibody fragments called minibodies that maintain the exquisite specificity of full-length antibodies while remaining inert in the body.
  • Used with widely available PET scan technology, these novel minibodies illuminate high-value molecular targets, providing physicians with a whole-body picture of immune activity.
  • ImaginAb is also developing a pipeline for other targets in oncology.
Tags: 
Medical specialties, Health, Immunology, Oncology, Cancer immunotherapy, Antibody, Therapy

Global Gene Therapy Technologies, Companies & Markets During the Forecast Period, 2018-2028 - ResearchAndMarkets.com

Wednesday, October 9, 2019 - 3:15pm

This report takes a broad overview of gene therapy and is the most up-to-date presentation from the author on this topic built-up from a series of gene therapy reports written by him during the past decade including a textbook of gene therapy and a book on gene therapy companies.

Key Points: 
  • This report takes a broad overview of gene therapy and is the most up-to-date presentation from the author on this topic built-up from a series of gene therapy reports written by him during the past decade including a textbook of gene therapy and a book on gene therapy companies.
  • Gene therapy is an excellent method of drug delivery and various routes of administration as well as targeted gene therapy are described.
  • The report also discusses the adverse effects of various vectors, safety regulations and ethical aspects of gene therapy including gene editing and germline gene therapy.
  • The markets for gene therapy have been difficult to estimate as there only a few approved gene therapy products Gene therapy markets are estimated for the years 2018-2028.
Tags: 
Health, Genetics, Branches of biology, Biology, Articles, Emerging technologies, Applied genetics, Biotechnology, Molecular biology, Bioethics, Gene therapy, Therapy, Gene editing, Designer baby

Jaylon Smith Opening Two Signature iCRYO Cryotherapy Locations in Indiana and Texas

Wednesday, October 9, 2019 - 1:31pm

HOUSTON, Oct. 9, 2019 /PRNewswire/ -- iCRYO, the leading Cryotherapy franchise in the United States, announced today that Equity Partner and Professional Football Player, Jaylon Smith, of the Dallas Cowboys, will be opening signature iCRYO locations in Frisco, TX and his hometown of Fort Wayne, IN.

Key Points: 
  • HOUSTON, Oct. 9, 2019 /PRNewswire/ -- iCRYO, the leading Cryotherapy franchise in the United States, announced today that Equity Partner and Professional Football Player, Jaylon Smith, of the Dallas Cowboys, will be opening signature iCRYO locations in Frisco, TX and his hometown of Fort Wayne, IN.
  • Smith recently signed a five-year contract extension with the Dallas Cowboys, ensuring he will be playing in Dallas long-term.
  • These two locations mark the first two of four that Smith will be opening, with future locations to come in Indianapolis, IN and Grapevine, TX.
  • iCRYO offers Whole Body Cryotherapy, Localized Cryotherapy and Cryotherapy Facials, Compression Therapy and Infrared Sauna, Vitamin IV Therapy, as well as Cryoskin Body Contouring services for body slimming and toning.
Tags: 
Health, Medicine, Bathing, Cryotherapy, Therapy, Sauna, Dallas, Infrared sauna, Jaylon Smith

Global Cell Therapy Technologies, Companies & Markets During the Forecast Period, 2018-2028 - ResearchAndMarkets.com

Wednesday, October 9, 2019 - 1:26pm

The "Cell Therapy - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cell Therapy - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
  • This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine.
  • Cell therapy technologies overlap with those of gene therapy, cancer vaccines, drug delivery, tissue engineering and regenerative medicine.
  • Safety is an essential consideration of any new therapy and regulations for cell therapy are those for biological preparations.
Tags: 
Pharmaceutical, Health, Stem cells, Branches of biology, Life sciences, Biology, Biotechnology, Emerging technologies, Stem cells, Medical genetics, Molecular biology, Therapy, Gene therapy, Cell therapy, Stem-cell therapy

Athletico Physical Therapy Opens in McKinney

Wednesday, October 9, 2019 - 1:00pm

MCKINNEY, Texas, Oct. 9, 2019 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in McKinney on September 30th and is conveniently located in the same shopping center as the Kroger Marketplace.

Key Points: 
  • MCKINNEY, Texas, Oct. 9, 2019 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in McKinney on September 30th and is conveniently located in the same shopping center as the Kroger Marketplace.
  • "I look forward to establishing a strong presence in the McKinney Community," said Marina McDonald, PT and Clinic Manager of Athletico McKinney.
  • "My goal is to become the physical therapy provider of choice in McKinney by delivering dedicated quality care focused on the patient in a professional, ethical and caring environment.
  • To learn more, or to schedule a free assessment, visit www.athletico.com/McKinney
    Services available at Athletico McKinney include:
    Physical therapy Our physical therapists treat you to reduce pain, improve or restore mobility, and to help you remain at your optimal health without further risk of injury.
Tags: 
Health, Medical specialties, Manual therapy, Physical exercise, Physical therapy, Sports medicine, Therapy